Glial Nrf2 signaling mediates the neuroprotection exerted by Gastrodia elata Blume in Lrrk2-G2019S Parkinson's disease.
Elliott, Christopher Jh
eLife Sciences Publications, Ltd
MetadataShow full item record
Lin, Y., Lin, C., Ho, E., Ke, Y., Petridi, S., Elliott, C. J., Sheen, L., & et al. (2021). Glial Nrf2 signaling mediates the neuroprotection exerted by Gastrodia elata Blume in Lrrk2-G2019S Parkinson's disease.. Elife, 10 https://doi.org/10.7554/eLife.73753
The most frequent missense mutations in familial Parkinson's disease (PD) occur in the highly conserved LRRK2/PARK8 gene with G2019S mutation. We previously established a fly model of PD carrying the LRRK2-G2019S mutation that exhibited the parkinsonism-like phenotypes. An herbal medicine, Gastrodia elata Blume (GE), has been reported to have neuroprotective effects in toxin-induced PD models. However, the underpinning molecular mechanisms of GE beneficiary to G2019S-induced PD remain unclear. Here, we show that these G2019S flies treated with water extracts of GE (WGE) and its bioactive compounds, gastrodin and 4-HBA, displayed locomotion improvement and dopaminergic neuron protection. WGE suppressed the accumulation and hyperactivation of G2019S proteins in dopaminergic neurons and activated the antioxidation and detoxification factor Nrf2 mostly in the astrocyte-like and ensheathing glia. Glial activation of Nrf2 antagonizes G2019S-induced Mad/Smad signaling. Moreover, we treated LRRK2-G2019S transgenic mice with WGE and found that the locomotion declines, the loss of dopaminergic neurons, and the number of hyperactive microglia were restored. WGE also suppressed the hyperactivation of G2019S proteins and regulated the Smad2/3 pathways in the mice brains. We conclude that WGE prevents locomotion defects and the neuronal loss induced by G2019S mutation via glial Nrf2/Mad signaling, unveiling a potential therapeutic avenue for PD.
BMP/Mad, D. melanogaster, Gastrodia elata Blume, Lrrk2, Nrf2, Parkinson's disease, glia, mouse, neuroscience, Animals, Benzyl Alcohols, Butyrates, Disease Models, Animal, Dopaminergic Neurons, Drosophila melanogaster, Gastrodia, Glucosides, Locomotion, Mice, NF-E2-Related Factor 2, Neuroglia, Neuroprotection, Neuroprotective Agents, Parkinson Disease, Plant Extracts, Signal Transduction
Ministry of Science and Technology, Taiwan (MOST-108-2311-B-001-039-MY3)
Parkinson's UK (H1201)
External DOI: https://doi.org/10.7554/eLife.73753
This record's URL: https://www.repository.cam.ac.uk/handle/1810/331861
Recommended or similar items
The current recommendation prototype on the Apollo Repository will be turned off on 03 February 2023. Although the pilot has been fruitful for both parties, the service provider IKVA is focusing on horizon scanning products and so the recommender service can no longer be supported. We recognise the importance of recommender services in supporting research discovery and are evaluating offerings from other service providers. If you would like to offer feedback on this decision please contact us on: firstname.lastname@example.org